Xilio Therapeutics Inc (XLO) 財務データ
*すべての数値は百万単位です
| 期間終了日 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|---|
| 期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
| Revenues | 47.79%18.69 | 12.65 | 13.69 | 19.07 | 8.08 |
17.10%22.18 | 26.76 | 25.52 | 21.00 | 22.45 | |
| Research and Development | 26.59%14.56 | 19.83 | 18.12 | 14.32 | 15.33 |
| Operating Income/Loss | 75.26%-3.49 | -14.11 | -11.84 | -1.93 | -14.37 |
| Nonoperating Income/Loss | 162.88%-2.88 | 4.58 | 22.20 | -14.36 | -1.48 |
33.12%-6.37 | -9.53 | 10.36 | -16.29 | -15.84 | |
| Attributable To Parent | 33.12%-6.37 | -9.53 | 10.36 | -16.29 | -15.84 |
| Basic Average Shares | 18.70%19.40 | 16.35 | - | 144.11 | 96.45 |
| Basic Earnings Per Share | 43.10%-0.33 | -0.58 | - | -0.11 | -0.16 |
| Diluted Earnings Per Share | 43.10%-0.33 | -0.58 | - | -0.11 | -0.16 |